Allocating Funds: Ensuring sufficient funding for cancer research institutions and projects. Facilitating Collaborations: Promoting partnerships between research institutions, pharmaceutical companies, and international organizations. Streamlining Regulations: Simplifying the regulatory process for clinical trials and new drug approvals. Encouraging Innovation: Providing incentives for the development of innovative cancer therapies and technologies.
